iMETX (Individualized Metabolic RX): a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
Breast Cancer
Interventions
BEHAVIORAL

iMETX intervention

"Pre-intervention the participants will wear the running watch for 3 weeks so that researchers can collect data about their daily routines regarding where and how much energy they expend.~During the intervention participants will wear the running watch for 12 weeks. Every 1-3 days the participants will be given an individualized recommendation for how to increase their activity via the iMETX application. Participants will be able to provide feedback to the researchers throughout intervention period regarding what works and does not in terms of the recommendations for increasing activity.~Post-intervention the participants will wear the running watch for 12 weeks so that researchers can collect data in order to determine whether physical activity changes made during the intervention are sustained."

Trial Locations (4)

46032

Indiana University Health North Hospital, Carmel

46202

Indiana University Health Hospital, Indianapolis

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis

46290

Spring Mill Medical Center, Indianapolis

All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

collaborator

University of Wisconsin, Madison

OTHER

lead

Indiana University

OTHER

NCT03158519 - iMETX (Individualized Metabolic RX): a Pilot Study | Biotech Hunter | Biotech Hunter